Low-energy Shock Wave Therapy—A Novel Treatment Option for Erectile Dysfunction in Men With Cardiovascular Disease

Patients with cardiovascular disease (CVD) are prone to developing erectile dysfunction (ED) owing to the common risk factors and pathogenesis underlying ED and CVD. As a result, ED affects nearly 80% of male patients with CVD. The efficacy of phosphodiesterase type 5 inhibitors, vacuum erection devices, or intracavernosal injection of vasodilating agents is well established in the treatment of ED; however, their use is limited. Low-energy shock wave therapy is a novel modality that may become a causative treatment for ED. This review aims to assess the efficacy and safety of low-energy shock wave therapy in the treatment of ED in men with CVD.

Authors:
Dariusz Kałka, Jana Gebala, Ryszard Smolin ́ski, Lesław Rusiecki, Witold Pilecki, and Romuald Zdrojowy
From the Cardiosexology Unit, Department of Pathophysiology, Wrocław Medical University, Wrocław, Poland; Centre for Men’s Health, Wrocław, Poland; the Cardiosexology Students’ Scientific Club, Wrocław Medical University, Wrocław, Poland; the University Hospital of Wrocław Medical University, Wrocław, Poland; and the Department and Clinic of Urology, Wroclaw Medical University, Wrocław, Poland

Urology. 2017 Nov;109:19-26. doi: 10.1016/j.urology.2017.05.030. Epub 2017 May 29.

Login